GlycoNex (ROCO:4168) COGS-to-Revenue : 0.14 (As of Mar. 2025)

View and export this data going back to 2012. Start your Free Trial

What is GlycoNex COGS-to-Revenue?

GlycoNex's Cost of Goods Sold for the three months ended in Mar. 2025 was NT$1.83 Mil. Its Revenue for the three months ended in Mar. 2025 was NT$13.57 Mil.

GlycoNex's COGS to Revenue for the three months ended in Mar. 2025 was 0.14.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. GlycoNex's Gross Margin % for the three months ended in Mar. 2025 was 86.49%.

GlycoNex COGS-to-Revenue Historical Data

The historical data trend for GlycoNex's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlycoNex COGS-to-Revenue Chart

GlycoNex Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

COGS-to-Revenue

Get a 7-Day Free Trial

0.72

0.37

0.54

0.61

0.50

GlycoNex Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
COGS-to-Revenue	Get a 7-Day Free Trial															0.39	0.25	0.68	0.71	0.14

GlycoNex COGS-to-Revenue Calculation

GlycoNex's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	7.38	/	14.701
	=	0.50

GlycoNex's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1.833	/	13.569
	=	0.14

GlycoNex (ROCO:4168) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

GlycoNex's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	1.833 / 13.569
	=	86.49 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

GlycoNex COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of GlycoNex's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

GlycoNex Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GlycoNex Inc (ROCO:4168) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Section 1, Xintai 5th Road, 8th Floor, No. 97, Xizhi District, New Taipei City, TWN, 221

Website

http://www.glyconex.com.tw

GlycoNex Inc is a Taiwan based company engaged in the development of cancer drugs from the combination of glycosphingolipid antigen and human monoclonal antibody technologies. It has a panel of antibodies that targets various carbohydrate antigens. The antibodies are cloned from hybridoma, engineered to improve stability, and can serve as reagents with applications that include ELISA, Western blot, flow cytometry, and TLC immunostaining. The Company also provides antibody research services to its academic and industrial clients. The other services provided by the firm include functional evaluation and antibody engineering. The company has two segments which are antibody new drugs and exclusive investment. It earns the majority of its revenue from the antibody new drugs segment.

GlycoNex Headlines

No Headlines